1.O’Brien TP. Emerging guidelines for the use of NSAID therapy to optimize cataract surgery and patient care. Curr Med Res Opin. 2005;21:1131–1137.
2. McColgin AZ, Raizman MB. Efficacy of topical Voltaren in reducing the incidence of postoperative cystoid macular edema. Invest Ophthalmol Vis Sci. 1999;40:S289.
3. Heier JS, Topping TM, Baumann W, et al. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.Ophthalmol. 2000;107:2034–2038.Global Experience With Xibrom ’ 37
4. Bronuck] package insert. Senju Pharmaceutical Company, Ltd, Osaka, Japan, 2003.
5. Xibromt (bromfenac ophthalmic solution) 0.09% prescribing information. ISTA Pharmaceuticals], Inc. 2005.
6. Xibromt (bromfenac ophthalmic solution) 0.09% prescribing information. ISTA Pharmaceuticals], Inc. 2006
Síntesis y traducción: Dr. Martín Mocorrea, editor responsable de Intramed en la especialidad de oftalmología.